India — National Centre for Disease Control & World Health Organization

India — National Centre for Disease Control: India — National Centre for Disease Control is coordinating with the Union Health Ministry of India and World Health Organization to monitor the hantavirus outbreak on MV Hondius and review preparedness measures.

World Health Organization: The World Health Organization>>> is actively coordinating the international response to the hantavirus outbreak, issuing guidelines, monitoring cases, and reassuring the public, thereby reinforcing its role in global health security.

India — National Centre for Disease Control: The India — National Centre for Disease Control>>> was directed to maintain readiness for tracking, testing, and surveillance of suspected Ebola infections in India>>>.

World Health Organization: The World Health Organization>>> declared the Ebola outbreak in Africa a 'Public Health Emergency of International Concern,' prompting global surveillance measures, including those in India>>>.

India — National Centre for Disease Control: Coordinating disease surveillance and activated its Public Health Emergency Operations Centre to support the response.

World Health Organization: Provided background information on the virus, including transmission and case-fatality rates, but is not directly involved in the response.

India — National Centre for Disease Control: The India — National Centre for Disease Control is tasked with maintaining readiness for tracking, testing, and surveillance of Ebola, supporting India's public health response.

World Health Organization: The World Health Organization's declaration of the Ebola outbreak as a Public Health Emergency of International Concern has prompted India to intensify its precautionary measures.

India — National Centre for Disease Control: NCDC is another designated referral laboratory, supporting testing and surveillance efforts.

World Health Organization: WHO is referenced for its classification of H1N1 as a seasonal virus and for identifying high-risk groups. Its guidance informs public health responses but has no direct market effect.